http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800703-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a8e13fa5efa680d41dd5e69ff160168 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-525 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate | 1996-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3394e170434eaa2ad2df1536d10ecacf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b71ef3dbe738e28f52efe5e066a54708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2b9872b746d7fa37d33f1202c0af01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7cc8b37ddbcf1015bad892747f10122 |
| publicationDate | 1998-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9800703-A1 |
| titleOfInvention | Test strip including integral specimen flow retarding structure |
| abstract | A test strip (20) includes a first layer (24) and an overlying differential flow-retarding layer (26) that reduces the fraction of a component of a liquid specimen percolated therethrough. An inert backing (28), preferably having an aperture (30) therethrough, overlies the flow-retarding layer (26). For the testing of a blood specimen, the flow-retarding layer (26) is formed of glass fibers that reduce the fraction of red blood cells in the percolate, leaving primarily, but not entirely, plasma in the percolate. The first layer (24) includes chemicals that react with a component of the plasma such as glucose in a measurable reaction, preferably a visually measurable reaction. In using this test strip (20), the blood specimen is placed into the aperture (30) of the backing (28) and permitted to percolate through the flow-retarding layer (26) such that a fraction of the red blood cells is removed from the percolate. The chemicals in the first layer (24) react with the glucose in the plasma to produce a change that is visually measurable from the bottom side of the active layer with reduced visual interference from the red color of whole blood on the bottom side of the reaction layer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE41309-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8361386-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03089938-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8846328-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7115421-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8241588-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42924-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42953-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935497-B2 |
| priorityDate | 1996-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.